369 related articles for article (PubMed ID: 31617927)
1. Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders.
You JC; Jones E; Cross DE; Lyon AC; Kang H; Newberg AB; Lippa CF
JAMA Netw Open; 2019 Oct; 2(10):e1913383. PubMed ID: 31617927
[TBL] [Abstract][Full Text] [Related]
2. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.
Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P
JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
[TBL] [Abstract][Full Text] [Related]
4. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
5. Self-reported sleep and β-amyloid deposition in community-dwelling older adults.
Spira AP; Gamaldo AA; An Y; Wu MN; Simonsick EM; Bilgel M; Zhou Y; Wong DF; Ferrucci L; Resnick SM
JAMA Neurol; 2013 Dec; 70(12):1537-43. PubMed ID: 24145859
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
7. Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.
Gu Y; Razlighi QR; Zahodne LB; Janicki SC; Ichise M; Manly JJ; Devanand DP; Brickman AM; Schupf N; Mayeux R; Stern Y
PLoS One; 2015; 10(7):e0123743. PubMed ID: 26221954
[TBL] [Abstract][Full Text] [Related]
8. Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging.
Winer JR; Deters KD; Kennedy G; Jin M; Goldstein-Piekarski A; Poston KL; Mormino EC
JAMA Neurol; 2021 Oct; 78(10):1187-1196. PubMed ID: 34459862
[TBL] [Abstract][Full Text] [Related]
9. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
10. Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults.
Insel PS; Mohlenhoff BS; Neylan TC; Krystal AD; Mackin RS
JAMA Netw Open; 2021 Jul; 4(7):e2117573. PubMed ID: 34297074
[TBL] [Abstract][Full Text] [Related]
11. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
12. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood.
Branger P; Arenaza-Urquijo EM; Tomadesso C; Mézenge F; André C; de Flores R; Mutlu J; de La Sayette V; Eustache F; Chételat G; Rauchs G
Neurobiol Aging; 2016 May; 41():107-114. PubMed ID: 27103523
[TBL] [Abstract][Full Text] [Related]
13. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.
Snitz BE; Lopez OL; McDade E; Becker JT; Cohen AD; Price JC; Mathis CA; Klunk WE
J Alzheimers Dis; 2015 Sep; 48 Suppl 1(0 1):S151-9. PubMed ID: 26402082
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.
Mormino EC; Betensky RA; Hedden T; Schultz AP; Amariglio RE; Rentz DM; Johnson KA; Sperling RA
JAMA Neurol; 2014 Nov; 71(11):1379-85. PubMed ID: 25222039
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
18. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
19. Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic Attack: Three-Year Longitudinal Study.
Liu W; Wong A; Au L; Yang J; Wang Z; Leung EY; Chen S; Ho CL; Mok VC
Stroke; 2015 Nov; 46(11):3074-80. PubMed ID: 26382174
[TBL] [Abstract][Full Text] [Related]
20. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
Donohue MC; Sperling RA; Petersen R; Sun CK; Weiner MW; Aisen PS;
JAMA; 2017 Jun; 317(22):2305-2316. PubMed ID: 28609533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
